Ken Uehara - Taisho Pharmaceutical MD Director
| TAIPYDelisted Stock | USD 14.00 0.00 0.00% |
Director
Mr. Ken Uehara was serving as Director in TAISHO PHARMACEUTICAL HOLDINGS CO., LTD., as well as Chairman of the Board of a subsidiary, since June 2017. He is also in charge of Finance Legal Affairs of the Company. He is also serving as Vice President and Representative Director in a subsidiary, TAISHO PHARMACEUTICAL CO., LTD., as well as Director in another subsidiary, Taisho Toyama Pharmaceutical Co., Ltd. He used to serve as Managing Director of the Company. since 2017.
| Age | 40 |
| Tenure | 7 years |
| Phone | 81 3 3985 2020 |
| Web | https://www.taisho-holdings.co.jp |
Taisho Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of 0.0183 % which means that it generated a profit of $0.0183 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0345 %, meaning that it generated $0.0345 on every $100 dollars invested by stockholders. Taisho Pharmaceutical's management efficiency ratios could be used to measure how well Taisho Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Rolf Classon | Catalent | 75 | |
| BSE CS | HUTCHMED DRC | 72 | |
| Ronald Richard | Emergent Biosolutions | 64 | |
| Gregory Lucier | Catalent | 56 | |
| Art Garcia | Elanco Animal Health | 59 | |
| Denise ScotsKnight | Elanco Animal Health | 61 | |
| David Ricks | Elanco Animal Health | 52 | |
| Prasad Menon | Dr Reddys Laboratories | 74 | |
| Rosemary Crane | Teva Pharma Industries | 60 | |
| Aarti Shah | Elanco Animal Health | 55 | |
| Arunabha RayChaudhuri | Dr Reddys Laboratories | N/A | |
| Kapila Anand | Elanco Animal Health | 67 | |
| JeanMichel Halfon | Teva Pharma Industries | 68 | |
| Bruce Carter | Dr Reddys Laboratories | 77 | |
| John Bilbrey | Elanco Animal Health | 64 | |
| Deborah Kochevar | Elanco Animal Health | 64 | |
| Leo Puri | Dr Reddys Laboratories | 59 | |
| Lawrence Kurzius | Elanco Animal Health | 63 | |
| Sue Bailey | Emergent Biosolutions | 76 | |
| Michael Barber | Catalent | 60 | |
| Bharat Doshi | Dr Reddys Laboratories | 71 | |
Management Performance
| Return On Equity | 0.0345 | |||
| Return On Asset | 0.0183 |
Taisho Pharmaceutical Leadership Team
Elected by the shareholders, the Taisho Pharmaceutical's board of directors comprises two types of representatives: Taisho Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Taisho. The board's role is to monitor Taisho Pharmaceutical's management team and ensure that shareholders' interests are well served. Taisho Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Taisho Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shigeru Uehara, Vice President and Presidentident of Subsidiary, Director | ||
| Shinichi Tanaka, Gen Communications | ||
| Akira Uehara, President Chairman of Subsidiary, Representative Director | ||
| Jinsei Maruyama, Co Officer | ||
| Tetsu Watanabe, Executive Director | ||
| Jun Kuroda, Ex Director | ||
| Ken Uehara, MD Director | ||
| Hideki Iuchi, G Mang | ||
| Hisashi Umeoka, Director |
Taisho Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Taisho Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0345 | |||
| Return On Asset | 0.0183 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 1.27 B | |||
| Shares Outstanding | 327.94 M | |||
| Price To Earning | 20.67 X | |||
| Price To Book | 0.57 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 268.2 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Taisho Pink Sheet
If you are still planning to invest in Taisho Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taisho Pharmaceutical's history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |